Source: Nextleaf Solutions Ltd.
  • Nextleaf Solutions (OILS) provided investors with an update on its patented novel route of manufacturing THC-O
  • Since it does not meet the definition of “Total THC” under the Excise Act 2001, THC-O is not subject to excise tax
  • Nextleaf sees potential to make its novel cannabinoid ingredient as an excise tax-free alternative to delta-9-THC with THC-O
  • Some cannabis products manufactured with delta-9-THC subject to excise tax over 40 per cent of the duty paid landed cost to provincial government distributors and medical cannabis distributors
  • THC-O products also have a more gradual onset, are longer-lasting, and have psychedelic-like effects, as compared to delta-9-THC
  • Nextleaf Solutions Ltd. was up 7.69 per cent, trading at $0.07 10:40 a.m. ET

Nextleaf Solutions (OILS) has provided an update on the manufacturing of D9-tetrahydrocannabinol acetate, known as THC-O.

Since it does not meet the definition of “Total THC” under the Excise Act 2001, which is aligned with the definition of the same in the Cannabis Act, based on the amount of total delta-9-THC present, THC-O is not subject to excise tax.

Nextleaf sees potential to make its novel cannabinoid ingredient as an excise tax-free alternative to delta-9-THC with THC-O.

Some cannabis products manufactured with delta-9-THC subject to excise tax over 40 per cent of the duty paid landed cost to provincial government distributors and medical cannabis distributors.

THC-O products also have a more gradual onset, are longer-lasting, and have psychedelic-like effects, as compared to delta-9-THC. The company’s patented THC-O manufacturing process enables the standardization of a more potent analog of THC.

Under its Health Canada Research Licence in anticipation of commercialization, Nextleaf recently produced THC-O and validated its manufacturing process through third-party analytical testing. The company holds U.S. and Canadian patents, along with a U.S. patent for a less efficient method to produce THC-O.

Nextleaf is a federally regulated manufacturer and distributor of cannabis vapes and oils under its award-winning prohibition-era brand, Glacial Gold.

Nextleaf Solutions Ltd. was up 7.69 per cent, trading at $0.07 10:40 a.m. ET.

More From The Market Online

The Market Online’s Weekly Cannabis Report – April 19, 2024

Cannabis news this week: Canopy Growth shareholders overwhelmingly voted to approve a new class of exchangeable shares.

Buzz on the Bullboards: Challenges amid inflation and geopolitical tensions

Canadian and U.S. stock markets grapple with a host of challenges, from surging inflation data to escalating tensions in the Middle East.

Xebra Brands receives second CBD approval by Mexican authority

Xebra Brands (CSE:XBRA) announces it has received its second COFEPRIS approval for CBD product authorization in Mexico.
Canopy Growth - CEO, David Klein.

Canopy Growth shareholders approve Canopy USA asset strategy

After rearranging its capital structure, Canopy Growth (TSX:WEED) will be closer to establishing a U.S.-based multi-state operator.